How will AI shape the future of Market Access and Systematic Reviews, Jeffrey Johnson and Kevin Kallmes?

This is a repost of a popular episode of MAP, Market Access Podcast, from 15th of July 2023.Even though there are great accelerators and a lot of innovative product ideas, only very few products actually make it to the market and are commercially successful. What is the reason behind that and even more important how could this situation be improved?In this podcast episode, Dr. Stefan Walzer and Dr. Kasia Hein-Peters are discussing the necessity for an overarching business and company strategy approach. In health care this is sometimes referred to a lifecycle approach, the invented approach by Dr. Kasia Hein-Peters is called DIVE. Within these approaches, all stakeholders would always need to be captured and dealt with - clinical development, regulatory and payers.Stay updated for upcoming webinars through LinkedIn, and take the chance to stay connected through subscribing with your favorite podcasting platform or directly listen on our website: MAP Podcasts MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://marketaccess4-0.com/#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #pricingstrategy #innovation #pricing #drugs #medtech #livescience #strategy

Join us on the latest episode of MAP - the Market Access Podcast - where our host Dr. Stefan Walzer, together with special guest Gerdi Strydom, Managing Director at Valid Insight, explore the integration of ESG (Environmental, Social, and Governance) into Health Technology Assessments (HTAs).In this episode, they unpack how healthcare's carbon footprint and environmental impact are influencing policy, payor decisions, and industry strategies. Discover how leaders are addressing these challenges, the steps being taken in regions like the Nordics and the UK, and what the future holds for low-carbon pharmaceuticals.This episode is for anyone who wants to get a better understanding of the growing role of environmental factors in HTAs as well as how global collaboration can drive sustainability in healthcare. Stay ahead of the trends in market access, and join the conversation around sustainability’s role in healthcare. Tune in now!Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://marketacces4-0.dewww.marketaccess4-0.com/#MarketAccess #HealthcareInnovation #Sustainability #HTA #Pharma #ESG #marketaccess #marketaccesspodcast

This is a repost of a popular MAP, Market Access Podcast, from 1st of January 2023. Companies launching oncology drugs sometimes struggle with existing reimbursement pathways and negotiations with payers, mainly in Europe, but also in other parts of the world. Evidence generation is the start of every drug development, but especially in oncology the design is important – not only that payers want to get a proof of a longer survival, but they also have further needs in their internal assessment. Enjoy the insights shared by the oncology market access veterans Dr. Stefan Walzer and Ed Schoonveld. Stay updated for upcoming webinars through LinkedIn, and take the chance to stay connected through subscribing with your favorite podcasting platform or directly listen on our website: MAP Podcasts MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://marketaccess4-0.com/ #podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #pricingstrategy #negotiations #pricing #germany #Europe #oncology 

This is a repost of a popular MAP, Market Access Podcast, from January 2023. A strong evidence package is important as a solid base for health technology assessments and the following price negotiations with health care payers. It is widely agreed, that randomized controlled trials are the gold standard in HTA, but there are also strong advocates of real-world evidence as a complementary way to measure the effectiveness of treatments. One of these advocates is Dr. Karen Facey and so Dr. Stefan Walzer brought her on the podcast and asked all the tough questions about real world evidence and the reality with payers around the world. Are there opportunities in such RWE data or is that a dead-end?  Take the chance to stay connected and subscribe with your favourite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://marketacces4-0.dewww.marketaccess4-0.com/ #podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #pricingstrategy #negotiations #pricing #hta #pharma #healthcare #realworldevidence #rwe 

In this repost of MAP, the Market Access Podcast, from 15th of September 2023, you’ll hear from Dr Stefan Walzer and Dr Mike Rosenblatt as they’re discussing the age we are currently in of massive medical innovation, including a lot of new modalities especially in the area of ATMPs, and this insightful conversation highlights some core questions:- What are the differences between Clinical Development and Medical Affairs?- When should a company start telling their medical story about a new product?- What are the differences between drugs and vaccinations from a medical affairs’ perspective?- ... and how should market access and medical affairs ideally work together?Tune in to listen to the Market Access veteran Dr. Stefan Walzer and Dr. Mike Rosenblatt, one of the pioneers in Medical Affairs, Commercialisation and Market Access, as they continued their conversation from Boston, May 2023, through this epic podcast episode.Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://marketacces4-0.dewww.marketaccess4-0.com/#Medtech #MarketAccess #US #HealthcareSystem #marketaccess #marketaccesspodcast #pricing #medtech #pharmaceuticals #innovation #vaccination

Tune in to the latest episode of MAP, the Market Access Podcast, hosted by Dr Stefan Walzer. In this summer special you will hear some profound insights from the recent MArS Webinar about the new platform DO-Bo - the first and only AI bot for creating reimbursement dossiers globally. Alongside Dr. Stefan Walzer you will also hear from Aleksey Zavgorodniy from Ukraine as they dive deep into how large language models are revolutionizing healthcare dossier writing.The journey to create DO-Bo highlighted unique challenges and innovative solutions. Integrating expert knowledge with AI, maintaining data security, and optimizing data processing were key to DO-Bo's success. Explore how DO-Bo can save time and enhance quality in your market access strategies. Interested in transforming your dossier writing process? Request a live demo today and witness firsthand how DO-Bo is redefining healthcare dossier creation.Stay updated about upcoming webinars through LinkedIn, and take the chance to stay connected through subscribing with your favorite podcasting platform or directly listen on our website: MAP Podcasts MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://marketaccess4-0.com/#Medtech #MarketAccess #DO-Bo #HealthcareSystem #dossierwriting #marketaccess #marketaccesspodcast #dossier #webinar

Join us on the latest episode of MAP - the Market Access Podcast - hosted by Dr. Stefan Walzer, as we delve into the dynamic world of market access in Turkey. This episode features Oznur Seyhun, from Market Access Today, who brings expertise from over 20 years of experience in pharmaceutical chemistry, economics, and global management.Explore the latest trends in healthcare market access in Turkey, and discover how they are adapting to economic challenges like inflation and currency fluctuations. Learn about the introduction of Multi-Criteria Decision Analysis (MCDA) in reimbursement submissions, the rise of digital health solutions, and patient support programs.This episode is for anyone looking to deepen their understanding of why Turkey remains an attractive market for pharmaceutical companies despite economic pressures, with insights into local manufacturing incentives and the evolving private sector.Tune in to gain a comprehensive understanding of the current landscape and future prospects of market access in Turkey. Don’t miss out on this insightful discussion!Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: www.marketaccess4-0.com/#MarketAccess #HealthcareInnovation #DigitalHealth #Turkey #HealthcareSystem #marketaccess #marketaccesspodcast #medtech

Unlock the Future of Market Access with AI and Systematic Literature Reviews! Join Dr. Stefan Walzer in the latest episode of the Market Access Podcast as he delves into the transformative power of AI in systematic literature searches. Featuring Jeffrey Johnson and Kevin Kallmes from Nested Knowledge, this episode explores how their innovative platform revolutionizes literature reviews, making them faster, more efficient, and more enjoyable.This episode is for anyone who wants to learn more about the integration of AI in market access, reimbursement planning, and dossier creation. Tune in to find out how AI is not only saving time but also enhancing the quality of research and market access strategies. Don’t miss this insightful discussion on the future of AI in healthcare!Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: www.marketaccess4-0.com/#MarketAccess #AI #SystematicReview #HealthcareInnovation #Pharma #marketaccess #marketaccesspodcast

Tune in to the new episode of the Market Access Podcast (MAP), where Dr. Stefan Walzer, a pioneer in Market Access 4.0, explores groundbreaking solutions and innovative technologies shaping the future of healthcare reimbursement. Discover how AI-based platforms like Q-Bo and Wafle are revolutionizing health care trainings with all stakeholders.Special guest Rodrigo Silva shares his insights on the transformative power of virtual reality in healthcare, from enhancing nurse training to potential applications in the pharmaceutical industry. Discover how these technologies are revolutionizing market access and how digital health platforms can address critical healthcare challenges like nursing shortages. Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: www.marketaccess4-0.com#MarketAccess #AI #VirtualReality #HealthcareInnovation #Pharma #marketaccess #marketaccesspodcast #FutureOfHealthcare"

In the latest episode of MAP - the Market Access Podcast, Dr. Stefan Walzer discusses the transformative power of AI with industry veteran Sandip Shah. With over three decades in healthcare, Sandip shares his journey from sales rep to running Market Access Solutions, emphasizing on how AI is reshaping the landscape. Discover how AI is revolutionizing market research, streamlining dossier preparation, and reshaping pricing strategies. This episode is for anyone who wants to dive deep into how the potential of AI in enhancing market research through emotion recognition and data analysis can significantly impact payer research and training for sales reps. Imagine having comprehensive dossiers at your fingertips in the future, reducing preparation time from months to seconds.Listen now to explore how AI is set to redefine market access, driving efficiency and innovation in ways we've only begun to imagine. Stay ahead of the curve and join the conversation on how AI will shape our industry's future!Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de#MarketAccess #AI #HealthcareInnovation #HealthcareSystem #marketaccess #marketaccesspodcast